ArticleFrontiers in pharmacology2022

A double-blind, randomized, placebo-controlled, single-center clinical trial of jiaotaiwan for the treatment of insomnia symptoms caused by disharmony of the heart and kidney.

Nengzhi Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.